Create Account
D
Appili Therapeutics Inc. APLI.TO
TSX
Recommendation
Sell
Prev Close
$0.055
Volume
--
Avg Vol (90D)
191,425
Market Cap
$4.98M
Dividend & Yield
--
52-Week Range
$0.035 - $0.17
P/E (TTM)
--
EPS (TTM)
-$0.1041
My Lists My Alerts
Report
Rating
Reward
D
Weak
Risk
D-
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
--
Solvency Index
Weak
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Appili Therapeutics Appoints Dr. Carl Gelhaus and Arthur Baran to support the ATI-1701 Biodefense Vaccine Program
1/17/2023 - Business Wire
Appili Therapeutics Announces Notice of Allowance from the U.S. Patent and Trademark Office for ATI-1501 Liquid Oral Reformulation of Metronidazole
1/13/2023 - Business Wire
Appili Therapeutics ATI-1701 Biodefense Vaccine Secures ~US$14 Million of Funding from the U.S. Department of Defense in Partnership with the U.S. Air Force Academy
11/14/2022 - Business Wire
Appili Therapeutics GAAP EPS of -C$0.04
11/10/2022 - SeekingAlpha.com: All News
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2023
11/10/2022 - Business Wire
Income Statement
Total Revenue (TTM)
$1.10M
EBITDA (TTM)
-$7.02M
EBIT (TTM)
-$7.03M
Net Income (TTM)
-$8.28M
Balance Sheet
Total Assets (Q)
$2.85M
Total Debt (Q)
$3.94M
Total Liabilities (Q)
$5.07M
Book Value Per Share (Q)
-$0.0183
Cash Flow
Cash from Operations (TTM)
-$13.95M
Cash from Investing (TTM)
$19.60K
Cash from Financing (TTM)
$7.99M
Net Change in Cash (TTM)
-$5.89M
Filings
Filing Date
Thursday, November 10, 2022
Period Date
Friday, September 30, 2022
Next Filing
Week of Feb 13 and 17 (est)
Price History
Loading...
Beta
0.59
7-Day Total Return
0.00%
30-Day Total Return
10.00%
60-Day Total Return
37.50%
90-Day Total Return
0.00%
Year to Date Total Return
22.22%
1-Year Total Return
-56.00%
2-Year Total Return
-95.00%
3-Year Total Return
-94.21%
5-Year Total Return
--
52-week Low
Nov 08, 2022 - $0.035
52-week High
Feb 28, 2022 - $0.17
Valuation
Market Cap
$4.98M - Nano Cap
Enterprise Value
$7.22M
Price/Sales (TTM)
6.11
Price/Book (Q)
-3.01
Dividends and Shares
Shares Outstanding
121.27M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.appilitherapeutics.com
Phone Number
Address
#21-1344 Summer Street
Halifax, NS B3H 0A8
Country
Canada
Year Founded
2015
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective... more
Weiss Ratings